• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

9.200 -0.290 (-3.06%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
21 22 Next >
How Healthcare eCommerce Impacts Traditional Providers of Healthcare
August 14, 2023
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q2 2023 Results, Presents Updated Findings from Potentially Pivotal Study of Berubicin
August 14, 2023
Via Investor Brand Network
CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Results from On-Going Potentially Pivotal Study of Berubicin in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy
August 14, 2023
Via ACCESSWIRE
CNS Pharmaceuticals Reports Second Quarter 2023 Financial Results and Reiterates Upcoming Milestones
August 14, 2023
Via ACCESSWIRE
Israeli Company Seeks to Develop Micro-Robots to Boost Precision Medicine
August 10, 2023
Via Investor Brand Network
CNS Pharmaceuticals to Present at Benzinga's Virtual Biotech Conference
August 03, 2023
Via ACCESSWIRE
Researchers Trace Glioma Brain Tumor Origins to Epigenome
July 31, 2023
Via Investor Brand Network
CNS Pharmaceuticals to Participate in the Virtual Investor Summer Spotlight Series
July 05, 2023
Via ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Distinguished with Unique Capabilities
August 07, 2023
Via Investor Brand Network
CNS Pharma's Lead Drug Candidate Crosses The Blood Brain Barrier - What Does That Mean? Watch the full show here!
August 07, 2023
Watch the full show here! John Climaco, Chairman & CEO of CNS Pharmaceuticals (NASDAQ: CNSP) presented at Benzinga’s webinar: Pharma Companies Vs. A Tough Macro Backdrop. 
Via Benzinga
Researchers Unlock Previously Unknown Weakness of Brain Cancer
August 04, 2023
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports on Berubicin Pivotal Study, Announces Participation in Biotech Conference
August 03, 2023
Via Investor Brand Network
CNS Pharmaceuticals (NASDAQ:CNSP) to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
June 14, 2023
Via ACCESSWIRE
CNS Pharmaceuticals Provides Clinical Trial Update for Ongoing Potentially Pivotal Study with Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
August 03, 2023
Via ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Abstract Selected for Poster Presentation at 2023 SNO/ASCO CNS Cancer Conference
July 27, 2023
Via Investor Brand Network
CNS Pharmaceuticals (NASDAQ:CNSP) Announces Acceptance of Abstract for Poster Presentation at the 2023 SNO/ASCO CNS Cancer Conference
July 27, 2023
Via ACCESSWIRE
Clinical Trial Testing Modified Viruses as Brain Cancer Treatment Begins
July 25, 2023
Via Investor Brand Network
National GBM Awareness Events Underscore Significance of Clinical Trial Progress for CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)
July 21, 2023
Via Investor Brand Network
Doctors Use Melanoma Drugs to Shrink Brain Tumors by 90% in Small Study
July 19, 2023
Via Investor Brand Network
Harvard Scientists Create AI Tool to Provide Real-Time Genetic Analysis of Brain Cancer During Surgery
July 14, 2023
Via Investor Brand Network
Topics Artificial Intelligence
Biochemist Working to Make Chemo Sans Side Effects
July 07, 2023
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in July’s Virtual Investor Summer Spotlight Series
July 05, 2023
Via Investor Brand Network
Immunotherapy Implants Could Turn Tumor Cells on Each Other
June 30, 2023
Via Investor Brand Network
Virus Therapy Plus Radiation Could Improve Brain Tumor Treatment, Study Finds
June 26, 2023
Via Investor Brand Network
Experimental Vaccine Brings Hope of Slowing Glioblastoma Tumor Regrowth
June 20, 2023
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Maxim Group Virtual Healthcare Conference
June 15, 2023
Via Investor Brand Network
Researchers Explain How Brain Cancers Hijack Neural Circuits
June 13, 2023
Via Investor Brand Network
Scientists Create Open-Source Platform to Analyze Brain Tumors in Kids
June 07, 2023
Via Investor Brand Network
Biotechs Zeroing In on Developing Breakthrough Therapeutics for Metastatic Breast Cancer
June 05, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NASDAQ:RAIN),(NASDAQ:CNSP),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
12 Health Care Stocks Moving In Friday's Intraday Session
June 02, 2023
 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
21 22 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap